Taken together, these data suggested that, in addition to promoting the metastatic phenotypes of MDA-MB-231 cells, M protein also induces the paracrine effects of MDA-MB-231 cells on other non-aggressive BCC, thereby facilitating cancer progression. Here, MYOM2 is linked to cancer.